Skip to main content
. 2021 Jun 17;12:600999. doi: 10.3389/fpsyg.2021.600999

Table 1.

The underlying circuits of stress-induced mood disorders and its influencing factors.

Stress paradigms Region targeted Neuron Opsin(s) Manipulation (Activation/Inhibition) Test/behaviors Findings References
VTA to mPFC CSDS (10days) VTA DA ChR2 OA (20 Hz, 5 spikes, 10 s interval) SPT↓
SI↓
Increase depression-like phenotypes with activation Chaudhury et al., 2013
CSDS (10days) VTA to mPFC DA ChR2 OA (20 Hz,8 s, 2 s interval) SPT↔
SI↔
No depressive effect with activation Chaudhury et al., 2013
CSDS (10days) VTA to mPFC DA NpHR OI (20 Hz, 8 s, 2 s interval) SI↑
SPT↔
Increased depression-like phenotypes with inhibition Chaudhury et al., 2013
mPFC SDS mPFC N/A ChR2 OA (100 Hz, 1 s, 3 s interval) SPT↑
SI↑
Reduced depression-like phenotypes with activation Covington et al., 2010
SDS mPFC N/A ChR2 OA (100 Hz, 1 s, 3 s interval) EPM↔
OPT↔
No anxiogenic effect with activation Covington et al., 2010
SDS mPFC N/A ChR2 OA (100 Hz, 1 s, 3 s interval) Social recognition test↔ No cognitive effect with activation Covington et al., 2010
FST mPFC 5-HT ChR2 OA (20 Hz 5 ms) FST↔
OFT↔
No depressive effect with activation Warden et al., 2012
susceptible mice mPFC (PrL) N/A ChR2 OA (2.5 mW, 1 min) OFT↑ Have anti-depressive effect with activation Kumar et al., 2013
susceptible mice mPFC (PrL) N/A ChR2 OA (2.0 mW, 5 min) FST↑
OFT↑
Have anti-depressive effect with activation Kumar et al., 2013
CSDS (15 days) mPFC (PrL) N/A ChR2 OA (2.0 mW, 5 min) EPM↑ Reduced anxiolytic-like phenotypes with activation Kumar et al., 2013
CSDS (15 days) mPFC (PrL) N/A ChR2 OA (2.0 mW, 5 min) SI↔
OFT↔
No depressive effect with activation Kumar et al., 2013
susceptible mice mPFC (PrL) N/A ChR2 OA (100 Hz 40 ms, 3 s interval) N/A Have anti-depressive effect with activation Vialou et al., 2014
TST, electric shock mPFC (PL) N/A C1V1 OA (2 mW/pulses, 46 pulses/30 ms, 3s, 36 ms interval) Decision test↓ Reduced social decision-making behaviors with activation Friedman et al., 2017
TST, electric shock mPFC(PL) N/A eArch OI (2 mW/pulses, 1 pulse 3 s) Decision test↑ Increased social decision-making behaviors with activation Friedman et al., 2017
TST mPFC Glu ChR2 OA high-frequency (100 Hz, 1 s, 3 s interval) TST↑ Reduced depression-like phenotypes with activation Son et al., 2018
FST mPFC Drd1 DA ChR2 OA (5 mW/side, 10 Hz, 15 ms, 1 min on/1 min off, 60 min) FST↑
SPT↔
Reduced depression-like phenotypes with activation Hare et al., 2019
FST mPFC Drd1 DA ChR2 OA (5 mW/side, 10 Hz, 15 ms, 1 min on/1 min off, 60 min) EPM↑
NSF↔
No anxiogenic effect with activation Hare et al., 2019
FST mPFC Drd2 DA ChR2 OA (5 mW/side, 10 Hz, 15 ms, 1 min on/1 min off, 60 min) FST↔
SPT↔
No depressive effect with activation Hare et al., 2019
FST mPFC Drd2 DA ChR2 OA (5 mW/side, 10 Hz, 15 ms, 1 min on/1 min off, 60 min) EPM↓
NSF↔
Reduced anxiolytic-like phenotypes with activation Hare et al., 2019
mPFC-AMY CSDS (10 days) mPFC (PrL)-BLA Glu ChR2 OA (100 Hz, 40 ms, 3 s interval) SI↔
SPT↔
No depressive effect with activation Vialou et al., 2014
CSDS (10 days) mPFC (PrL)-BLA Glu ChR2 OA (100 Hz, 40 ms, 3 s interval) EPM↑ Reduced anxiolytic-like phenotypes with activation Vialou et al., 2014
mPFC-Striatum CSDS (10 days) mPFC (PrL)-NAc Glu ChR2 OA (100 Hz, 40 ms, 3 s interval) SI↑
SPT↑
Reduced depression-like phenotypes with activation Vialou et al., 2014
CSDS (10 days) mPFC (PrL)-NAc Glu ChR2 OA (100 Hz, 40 ms, 3 s interval) EPM↔ No anxiogenic effect with activation Vialou et al., 2014
mPFC- Thal FST mPFC-LHB N/A ChR2 OA (20 Hz, 5 ms) FST↓ Increased depression-like phenotypes with activation Warden et al., 2012
TST mPFC (IL)-Thal N/A ChETA OA (5 Hz, 15 ms interval/ 14.05 Hz) TST↑
OFT↔
Reduced depression-like phenotypes with activation Carlson et al., 2017
SDS DP/DTT → DMH N/A iChloC OI (10 Hz, 30/180 s) SI↑, OFT↑ Reduced depression-like phenotypes with inhibition Kataoka et al., 2020
susceptible mice DP/DTT → DMH Glu ChIEF OA (10 Hz, 30/180 s) BAT↑ Induced psychosocial stress responses with inhibition Kataoka et al., 2020
mPFC-DRN FST mPFC-DRN Glu, GABA, 5-HT ChR2 OA (20 Hz, 5 ms) FST↑
OFT↑
Reduced depression-like phenotypes with activation Warden et al., 2012
CSDS (11days) vmPFC-DRN GABA ChR2 OA (7.33 mW mm−2, 25 hz, 10 ms, 20 min) SI↓ Increased depression-like phenotypes with activation Challis et al., 2014
CSDS (11days) vmPFC-DRN GABA Arch OI (7.05 mW mm−2, 20 min) SI↑ Reduced depression-like phenotypes with inhibition Challis et al., 2014

AMY, amygdala; 5-HT, serotonergic nucleus; BAT, brown adipose tissue; BLA, basolateral amygdala; ChETA, channelrhodopsin-2 variant; ChR2, channelrhodopsin-2; CSDS, chronic social defeat stress; DA, dopamine; DP, dorsal peduncular cortex; DTT, dorsal tenia tecta; DMH, dorsomedial hypothalamus; EPM, Elevated plus maze; FST, forced swim test (non-social stress model); GABA, γ-aminobutyric acid; Glu, glutamatergic; IL, infralimbic cortex; LH, lateral habenula; NAc, nucleus accumbens; NSF, novelty suppressed feeding test; OPT, open field test; OA, optogenetic activation; OI, optogenetic inhibition; SDS, social defeat stress; SI, Social interaction test; SPT, sucrose preference test; THal, Thalamus; TST, tail suspension test (non-social stress model).